Click for best price
RNAbased Biopharmaceuticals Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for RNA-based Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA-based Biopharmaceuticals. This report contains market size and forecasts of RNA-based Biopharmaceuticals in global, including the following market information:
Global RNA-based Biopharmaceuticals Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global RNA-based Biopharmaceuticals Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five RNA-based Biopharmaceuticals companies in 2022 (%)
The global RNA-based Biopharmaceuticals market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Therapeutics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of RNA-based Biopharmaceuticals include Pfizer, Roche, Sanofi-Aventis, Abbott Laboratories, Arrowhead Pharmaceuticals, Benitec Biopharma, Calimmune Inc, Dicerna and Gradalis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the RNA-based Biopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA-based Biopharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global RNA-based Biopharmaceuticals Market Segment Percentages, by Type, 2022 (%)
Therapeutics
Vaccines
Global RNA-based Biopharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global RNA-based Biopharmaceuticals Market Segment Percentages, by Application, 2022 (%)
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Global RNA-based Biopharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global RNA-based Biopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA-based Biopharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies RNA-based Biopharmaceuticals revenues share in global market, 2022 (%)
Key companies RNA-based Biopharmaceuticals sales in global market, 2018-2023 (Estimated), (K Units)
Key companies RNA-based Biopharmaceuticals sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA-based Biopharmaceuticals, market overview.
Chapter 2: Global RNA-based Biopharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of RNA-based Biopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA-based Biopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global RNA-based Biopharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
RNA-based Biopharmaceuticals Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RNA-based Biopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA-based Biopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA-based Biopharmaceuticals Overall Market Size
2.1 Global RNA-based Biopharmaceuticals Market Size: 2022 VS 2029
2.2 Global RNA-based Biopharmaceuticals Revenue, Prospects & Forecasts: 2018-2029
2.3 Global RNA-based Biopharmaceuticals Sales: 2018-2029
3 Company Landscape
3.1 Top RNA-based Biopharmaceuticals Players in Global Market
3.2 Top Global RNA-based Biopharmaceuticals Companies Ranked by Revenue
3.3 Global RNA-based Biopharmaceuticals Revenue by Companies
3.4 Global RNA-based Biopharmaceuticals Sales by Companies
3.5 Global RNA-based Biopharmaceuticals Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 RNA-based Biopharmaceuticals Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers RNA-based Biopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 RNA-based Biopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 RNA-based Biopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 RNA-based Biopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA-based Biopharmaceuticals Market Size Markets, 2022 & 2029
4.1.2 Therapeutics
4.1.3 Vaccines
4.2 By Type - Global RNA-based Biopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global RNA-based Biopharmaceuticals Revenue, 2018-2023
4.2.2 By Type - Global RNA-based Biopharmaceuticals Revenue, 2024-2029
4.2.3 By Type - Global RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
4.3 By Type - Global RNA-based Biopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global RNA-based Biopharmaceuticals Sales, 2018-2023
4.3.2 By Type - Global RNA-based Biopharmaceuticals Sales, 2024-2029
4.3.3 By Type - Global RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
4.4 By Type - Global RNA-based Biopharmaceuticals Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA-based Biopharmaceuticals Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Diabetes
5.1.4 Tuberculosis
5.1.5 Cardiovascular Diseases
5.1.6 Others
5.2 By Application - Global RNA-based Biopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global RNA-based Biopharmaceuticals Revenue, 2018-2023
5.2.2 By Application - Global RNA-based Biopharmaceuticals Revenue, 2024-2029
5.2.3 By Application - Global RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
5.3 By Application - Global RNA-based Biopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global RNA-based Biopharmaceuticals Sales, 2018-2023
5.3.2 By Application - Global RNA-based Biopharmaceuticals Sales, 2024-2029
5.3.3 By Application - Global RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
5.4 By Application - Global RNA-based Biopharmaceuticals Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global RNA-based Biopharmaceuticals Market Size, 2022 & 2029
6.2 By Region - Global RNA-based Biopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global RNA-based Biopharmaceuticals Revenue, 2018-2023
6.2.2 By Region - Global RNA-based Biopharmaceuticals Revenue, 2024-2029
6.2.3 By Region - Global RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
6.3 By Region - Global RNA-based Biopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global RNA-based Biopharmaceuticals Sales, 2018-2023
6.3.2 By Region - Global RNA-based Biopharmaceuticals Sales, 2024-2029
6.3.3 By Region - Global RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America RNA-based Biopharmaceuticals Revenue, 2018-2029
6.4.2 By Country - North America RNA-based Biopharmaceuticals Sales, 2018-2029
6.4.3 US RNA-based Biopharmaceuticals Market Size, 2018-2029
6.4.4 Canada RNA-based Biopharmaceuticals Market Size, 2018-2029
6.4.5 Mexico RNA-based Biopharmaceuticals Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe RNA-based Biopharmaceuticals Revenue, 2018-2029
6.5.2 By Country - Europe RNA-based Biopharmaceuticals Sales, 2018-2029
6.5.3 Germany RNA-based Biopharmaceuticals Market Size, 2018-2029
6.5.4 France RNA-based Biopharmaceuticals Market Size, 2018-2029
6.5.5 U.K. RNA-based Biopharmaceuticals Market Size, 2018-2029
6.5.6 Italy RNA-based Biopharmaceuticals Market Size, 2018-2029
6.5.7 Russia RNA-based Biopharmaceuticals Market Size, 2018-2029
6.5.8 Nordic Countries RNA-based Biopharmaceuticals Market Size, 2018-2029
6.5.9 Benelux RNA-based Biopharmaceuticals Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia RNA-based Biopharmaceuticals Revenue, 2018-2029
6.6.2 By Region - Asia RNA-based Biopharmaceuticals Sales, 2018-2029
6.6.3 China RNA-based Biopharmaceuticals Market Size, 2018-2029
6.6.4 Japan RNA-based Biopharmaceuticals Market Size, 2018-2029
6.6.5 South Korea RNA-based Biopharmaceuticals Market Size, 2018-2029
6.6.6 Southeast Asia RNA-based Biopharmaceuticals Market Size, 2018-2029
6.6.7 India RNA-based Biopharmaceuticals Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America RNA-based Biopharmaceuticals Revenue, 2018-2029
6.7.2 By Country - South America RNA-based Biopharmaceuticals Sales, 2018-2029
6.7.3 Brazil RNA-based Biopharmaceuticals Market Size, 2018-2029
6.7.4 Argentina RNA-based Biopharmaceuticals Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales, 2018-2029
6.8.3 Turkey RNA-based Biopharmaceuticals Market Size, 2018-2029
6.8.4 Israel RNA-based Biopharmaceuticals Market Size, 2018-2029
6.8.5 Saudi Arabia RNA-based Biopharmaceuticals Market Size, 2018-2029
6.8.6 UAE RNA-based Biopharmaceuticals Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer RNA-based Biopharmaceuticals Major Product Offerings
7.1.4 Pfizer RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche RNA-based Biopharmaceuticals Major Product Offerings
7.2.4 Roche RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Major Product Offerings
7.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi-Aventis Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Major Product Offerings
7.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Arrowhead Pharmaceuticals
7.5.1 Arrowhead Pharmaceuticals Company Summary
7.5.2 Arrowhead Pharmaceuticals Business Overview
7.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Major Product Offerings
7.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.5.5 Arrowhead Pharmaceuticals Key News & Latest Developments
7.6 Benitec Biopharma
7.6.1 Benitec Biopharma Company Summary
7.6.2 Benitec Biopharma Business Overview
7.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Major Product Offerings
7.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.6.5 Benitec Biopharma Key News & Latest Developments
7.7 Calimmune Inc
7.7.1 Calimmune Inc Company Summary
7.7.2 Calimmune Inc Business Overview
7.7.3 Calimmune Inc RNA-based Biopharmaceuticals Major Product Offerings
7.7.4 Calimmune Inc RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.7.5 Calimmune Inc Key News & Latest Developments
7.8 Dicerna
7.8.1 Dicerna Company Summary
7.8.2 Dicerna Business Overview
7.8.3 Dicerna RNA-based Biopharmaceuticals Major Product Offerings
7.8.4 Dicerna RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.8.5 Dicerna Key News & Latest Developments
7.9 Gradalis
7.9.1 Gradalis Company Summary
7.9.2 Gradalis Business Overview
7.9.3 Gradalis RNA-based Biopharmaceuticals Major Product Offerings
7.9.4 Gradalis RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.9.5 Gradalis Key News & Latest Developments
7.10 Quark
7.10.1 Quark Company Summary
7.10.2 Quark Business Overview
7.10.3 Quark RNA-based Biopharmaceuticals Major Product Offerings
7.10.4 Quark RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.10.5 Quark Key News & Latest Developments
7.11 RXi
7.11.1 RXi Company Summary
7.11.2 RXi RNA-based Biopharmaceuticals Business Overview
7.11.3 RXi RNA-based Biopharmaceuticals Major Product Offerings
7.11.4 RXi RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.11.5 RXi Key News & Latest Developments
7.12 Senesco
7.12.1 Senesco Company Summary
7.12.2 Senesco RNA-based Biopharmaceuticals Business Overview
7.12.3 Senesco RNA-based Biopharmaceuticals Major Product Offerings
7.12.4 Senesco RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.12.5 Senesco Key News & Latest Developments
7.13 Silence Therapeutics
7.13.1 Silence Therapeutics Company Summary
7.13.2 Silence Therapeutics RNA-based Biopharmaceuticals Business Overview
7.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Major Product Offerings
7.13.4 Silence Therapeutics RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.13.5 Silence Therapeutics Key News & Latest Developments
7.14 Silenseed
7.14.1 Silenseed Company Summary
7.14.2 Silenseed Business Overview
7.14.3 Silenseed RNA-based Biopharmaceuticals Major Product Offerings
7.14.4 Silenseed RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.14.5 Silenseed Key News & Latest Developments
7.15 Tekmira
7.15.1 Tekmira Company Summary
7.15.2 Tekmira Business Overview
7.15.3 Tekmira RNA-based Biopharmaceuticals Major Product Offerings
7.15.4 Tekmira RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.15.5 Tekmira Key News & Latest Developments
7.16 Alnylam Pharmaceuticals
7.16.1 Alnylam Pharmaceuticals Company Summary
7.16.2 Alnylam Pharmaceuticals Business Overview
7.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Major Product Offerings
7.16.4 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales and Revenue in Global (2018-2023)
7.16.5 Alnylam Pharmaceuticals Key News & Latest Developments
8 Global RNA-based Biopharmaceuticals Production Capacity, Analysis
8.1 Global RNA-based Biopharmaceuticals Production Capacity, 2018-2029
8.2 RNA-based Biopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global RNA-based Biopharmaceuticals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RNA-based Biopharmaceuticals Supply Chain Analysis
10.1 RNA-based Biopharmaceuticals Industry Value Chain
10.2 RNA-based Biopharmaceuticals Upstream Market
10.3 RNA-based Biopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 RNA-based Biopharmaceuticals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of RNA-based Biopharmaceuticals in Global Market
Table 2. Top RNA-based Biopharmaceuticals Players in Global Market, Ranking by Revenue (2022)
Table 3. Global RNA-based Biopharmaceuticals Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global RNA-based Biopharmaceuticals Revenue Share by Companies, 2018-2023
Table 5. Global RNA-based Biopharmaceuticals Sales by Companies, (K Units), 2018-2023
Table 6. Global RNA-based Biopharmaceuticals Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers RNA-based Biopharmaceuticals Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers RNA-based Biopharmaceuticals Product Type
Table 9. List of Global Tier 1 RNA-based Biopharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA-based Biopharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global RNA-based Biopharmaceuticals Sales (K Units), 2018-2023
Table 15. By Type - Global RNA-based Biopharmaceuticals Sales (K Units), 2024-2029
Table 16. By Application ? Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global RNA-based Biopharmaceuticals Sales (K Units), 2018-2023
Table 20. By Application - Global RNA-based Biopharmaceuticals Sales (K Units), 2024-2029
Table 21. By Region ? Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global RNA-based Biopharmaceuticals Sales (K Units), 2018-2023
Table 25. By Region - Global RNA-based Biopharmaceuticals Sales (K Units), 2024-2029
Table 26. By Country - North America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America RNA-based Biopharmaceuticals Sales, (K Units), 2018-2023
Table 29. By Country - North America RNA-based Biopharmaceuticals Sales, (K Units), 2024-2029
Table 30. By Country - Europe RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe RNA-based Biopharmaceuticals Sales, (K Units), 2018-2023
Table 33. By Country - Europe RNA-based Biopharmaceuticals Sales, (K Units), 2024-2029
Table 34. By Region - Asia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia RNA-based Biopharmaceuticals Sales, (K Units), 2018-2023
Table 37. By Region - Asia RNA-based Biopharmaceuticals Sales, (K Units), 2024-2029
Table 38. By Country - South America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America RNA-based Biopharmaceuticals Sales, (K Units), 2018-2023
Table 41. By Country - South America RNA-based Biopharmaceuticals Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer RNA-based Biopharmaceuticals Product Offerings
Table 48. Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche RNA-based Biopharmaceuticals Product Offerings
Table 52. Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Sanofi-Aventis Company Summary
Table 55. Sanofi-Aventis RNA-based Biopharmaceuticals Product Offerings
Table 56. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sanofi-Aventis Key News & Latest Developments
Table 58. Abbott Laboratories Company Summary
Table 59. Abbott Laboratories RNA-based Biopharmaceuticals Product Offerings
Table 60. Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Abbott Laboratories Key News & Latest Developments
Table 62. Arrowhead Pharmaceuticals Company Summary
Table 63. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Offerings
Table 64. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Arrowhead Pharmaceuticals Key News & Latest Developments
Table 66. Benitec Biopharma Company Summary
Table 67. Benitec Biopharma RNA-based Biopharmaceuticals Product Offerings
Table 68. Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Benitec Biopharma Key News & Latest Developments
Table 70. Calimmune Inc Company Summary
Table 71. Calimmune Inc RNA-based Biopharmaceuticals Product Offerings
Table 72. Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Calimmune Inc Key News & Latest Developments
Table 74. Dicerna Company Summary
Table 75. Dicerna RNA-based Biopharmaceuticals Product Offerings
Table 76. Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Dicerna Key News & Latest Developments
Table 78. Gradalis Company Summary
Table 79. Gradalis RNA-based Biopharmaceuticals Product Offerings
Table 80. Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Gradalis Key News & Latest Developments
Table 82. Quark Company Summary
Table 83. Quark RNA-based Biopharmaceuticals Product Offerings
Table 84. Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Quark Key News & Latest Developments
Table 86. RXi Company Summary
Table 87. RXi RNA-based Biopharmaceuticals Product Offerings
Table 88. RXi RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. RXi Key News & Latest Developments
Table 90. Senesco Company Summary
Table 91. Senesco RNA-based Biopharmaceuticals Product Offerings
Table 92. Senesco RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Senesco Key News & Latest Developments
Table 94. Silence Therapeutics Company Summary
Table 95. Silence Therapeutics RNA-based Biopharmaceuticals Product Offerings
Table 96. Silence Therapeutics RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Silence Therapeutics Key News & Latest Developments
Table 98. Silenseed Company Summary
Table 99. Silenseed RNA-based Biopharmaceuticals Product Offerings
Table 100. Silenseed RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Silenseed Key News & Latest Developments
Table 102. Tekmira Company Summary
Table 103. Tekmira RNA-based Biopharmaceuticals Product Offerings
Table 104. Tekmira RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Tekmira Key News & Latest Developments
Table 106. Alnylam Pharmaceuticals Company Summary
Table 107. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Offerings
Table 108. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Alnylam Pharmaceuticals Key News & Latest Developments
Table 110. RNA-based Biopharmaceuticals Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 111. Global RNA-based Biopharmaceuticals Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global RNA-based Biopharmaceuticals Production by Region, 2018-2023 (K Units)
Table 113. Global RNA-based Biopharmaceuticals Production by Region, 2024-2029 (K Units)
Table 114. RNA-based Biopharmaceuticals Market Opportunities & Trends in Global Market
Table 115. RNA-based Biopharmaceuticals Market Drivers in Global Market
Table 116. RNA-based Biopharmaceuticals Market Restraints in Global Market
Table 117. RNA-based Biopharmaceuticals Raw Materials
Table 118. RNA-based Biopharmaceuticals Raw Materials Suppliers in Global Market
Table 119. Typical RNA-based Biopharmaceuticals Downstream
Table 120. RNA-based Biopharmaceuticals Downstream Clients in Global Market
Table 121. RNA-based Biopharmaceuticals Distributors and Sales Agents in Global Market
List of Figures
Figure 1. RNA-based Biopharmaceuticals Segment by Type in 2022
Figure 2. RNA-based Biopharmaceuticals Segment by Application in 2022
Figure 3. Global RNA-based Biopharmaceuticals Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global RNA-based Biopharmaceuticals Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global RNA-based Biopharmaceuticals Revenue, 2018-2029 (US$, Mn)
Figure 7. RNA-based Biopharmaceuticals Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by RNA-based Biopharmaceuticals Revenue in 2022
Figure 9. By Type - Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 11. By Type - Global RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
Figure 12. By Type - Global RNA-based Biopharmaceuticals Price (USD/Unit), 2018-2029
Figure 13. By Application - Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 15. By Application - Global RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
Figure 16. By Application - Global RNA-based Biopharmaceuticals Price (USD/Unit), 2018-2029
Figure 17. By Region - Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global RNA-based Biopharmaceuticals Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 20. By Region - Global RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
Figure 21. By Country - North America RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 22. By Country - North America RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
Figure 23. US RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 24. Canada RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 27. By Country - Europe RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
Figure 28. Germany RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 29. France RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 31. Italy RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 32. Russia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 36. By Region - Asia RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
Figure 37. China RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 38. Japan RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 41. India RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 43. By Country - South America RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
Figure 44. Brazil RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales Market Share, 2018-2029
Figure 48. Turkey RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 49. Israel RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 51. UAE RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 52. Global RNA-based Biopharmaceuticals Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production RNA-based Biopharmaceuticals by Region, 2022 VS 2029
Figure 54. RNA-based Biopharmaceuticals Industry Value Chain
Figure 55. Marketing Channels
